Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-09-24 to 2026-09-29
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$46.3M
across 2 rounds
CO-INVESTORS
9
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-09-24 to 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Aptadir Therapeutics A preclinical biotech company developing a new class of RNA therapeutics | Seed Verified against 1 of 40 sources | $44.7M | 2026-09-29 | [ PART ] |
Aptadir Therapeutics A preclinical biotech company developing a new class of RNA therapeutics | Pre-seed Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.6M | 2024-09-24 | [ PART ] |